Clinical Trial

PSTB100 Study in Healthy Adult Subjects

Name: PSTB100 Study in Healthy Adult Subjects — clinical trial record (NCT07702279)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is a randomized, double-blind, placebo-controlled, dose-escalation， first-in-human clinical trial in healthy adults, designed to assess the safety, tolerability, and PK characteristics of PSTB100 tablets.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-07-08.

Trial Details

NCT Number	NCT07702279
Lead Sponsor	Prospect Therapeutics (Nanjing) Limited
Conditions	Healthy Adult Subjects
Enrollment	68 participants
Start Date	2026-07-28
Primary Completion	2027-06-12 (estimated)
Study Completion	2027-09-06 (estimated)
Updated on ClinicalTrials.gov	2026-07-16